Cossette

Cosette Pharmaceuticals is a specialty pharmaceutical company focused on the development, manufacturing, and commercialization of high-quality medications in the United States. The company specializes in complex dosage forms, including topicals, semi-solids, liquids, and injectables, with a primary therapeutic focus on dermatology, women's health, and cardiovascular medicine. Established in 2018 following the acquisition of Perrigo's generic assets by Avista Capital Partners, Cosette has rapidly expanded its portfolio through strategic acquisitions and internal research and development. The company operates a state-of-the-art manufacturing facility in Lincolnton, North Carolina, which supports its mission to provide accessible healthcare solutions. Cosette's commercial portfolio includes well-known branded products such as Vandazole and Veregen, alongside a robust line of generic medications.